A carregar...
Predictive proteomic signatures for response of pancreatic cancer patients receiving chemotherapy
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer that is characterized by its poor prognosis, rapid progression and development of drug resistance. Chemotherapy is a vital treatment option for most of PDAC patients. Stratification of PDAC patients, who would have a higher likel...
Na minha lista:
| Publicado no: | Clin Proteomics |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6636003/ https://ncbi.nlm.nih.gov/pubmed/31346328 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12014-019-9251-3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|